For global I/R protocol, three groups were used: (1) C57 (n = 4), (2) db/db (n = 4)-DMSO and db/db-Rapamycin (100 nM) (LC Laboratories, MA, USA) (n = 6). Isolated hearts were infused with DMSO (solvent for rapamycin) and rapamycin. The dose of rapamycin was chosen based on our previous studies on rapamycin-induced cardioprotection against I/R injury [9 (link), 29 (link)]. To investigate STAT3 signaling, four groups were used (n = 5): (1) WT-DMSO, (2) WT-Rapamycin, (3) STAT3-deficient-DMSO and (4) STAT3-deficient-Rapamycin. Also, we isolated primary adult cardiomyocytes from these groups of mice (n = 4). Protein was analyzed from the hearts following global I/R (n = 3). Experimental protocol is documented in Fig. 1.